The clinical evaluation of PON1 genetic variations’ (involving192 Q/R, 55 L/M and -107 C/C polymorphisms) influence on the effectiveness of atorvastatin administration was performed in Sicilian subjects with hypercholesterolemia. Here, PON1 is linked to Hypercholesterolemia.